free full access: Enabling Medication Management Through Health Information Technology

Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
www.ahrq.gov


Prepared by:
McMaster Evidence-based Practice Center
Hamilton, ON Canada

Conclusions.
MMIT is well-studied, although on closer examination of the literature the evidence is not uniform across phases of medication management, groups of people involved, or types of MMIT. MMIT holds the promise of improved processes; clinical and economics studies and the understanding of sustainability issues are lacking.

Secondary link (McMaster) including professional commentaries

Technology Review: Examining Individual Tumor Cells

Technology Review: Examining Individual Tumor Cells

Ontario Institute for Cancer Research Announces Three New Equity Investments -- TORONTO, April 26 /PRNewswire/ --

Note: press release has further information on the investments:

1)Novel Cellular Immunotherapy for Cancer;
2)Next Generation Biomarker Analysis Technology;
3)Rapid, Sensitive Technology for Biomarker Analysis

Three New Technologies for Beating Breast Cancer - Women's Health Online

* Intensity Modulated Radiation Therapy (IMRT)
* DyNeMo (analyzes networks of proteins in cancer cells)
* Automated Breast Volume Scanner (ABVS)